Related references
Note: Only part of the references are listed.Cytoscape 2.8: new features for data integration and network visualization
Michael E. Smoot et al.
BIOINFORMATICS (2011)
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization
Kuo-Jang Kao et al.
BMC CANCER (2011)
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Christos Hatzis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib
F. Takahashi et al.
ONCOGENE (2011)
Cistrome: an integrative platform for transcriptional regulation studies
Tao Liu et al.
GENOME BIOLOGY (2011)
Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
Elin Mollerstrom et al.
BMC CANCER (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer
Caryn S. Ross-Innes et al.
GENES & DEVELOPMENT (2010)
Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation
Santhi D. Konduri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
ChIP-Seq of ERα and RNA polymerase II defines genes differentially responding to ligands
Willem-Jan Welboren et al.
EMBO JOURNAL (2009)
Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-α and the REA corepressor
Sudipan Karmakar et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Sherene Loi et al.
BMC GENOMICS (2008)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
Estrogen receptor α inhibits p53-mediated transcriptional repression:: Implications for the regulation of apoptosis
Aejaz Sayeed et al.
CANCER RESEARCH (2007)
DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2007)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Molecular concepts analysis links tumors, pathways, mechanisms, and drugs
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Genome-wide analysis of estrogen receptor binding sites
Jason S. Carroll et al.
NATURE GENETICS (2006)
Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein
Jingyung Hur et al.
CANCER RESEARCH (2006)
Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein
Hirofumi Kawakubo et al.
CANCER RESEARCH (2006)
Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release
S Kansra et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll et al.
CELL (2005)
Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination
CH Yan et al.
EMBO JOURNAL (2005)
Estrogen-receptor biology: Continuing progress and therapeutic implications
CK Osborne et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor α (ERα), differentially affect ERα extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells
V Marsaud et al.
MOLECULAR ENDOCRINOLOGY (2003)
Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene
JK Sax et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antiestrogens are pro-apoptotic in normal human breast epithelial cells
S Somaï et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer
E Turpin et al.
ONCOGENE (2002)
Endocrine-responsive breast cancer and strategies for combating resistance
S Ali et al.
NATURE REVIEWS CANCER (2002)
The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators
AL Wijayaratne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
In search of a function for the TIS21/PC3/BTG1/TOB family
S Matsuda et al.
FEBS LETTERS (2001)
Selective estrogen receptor modulators: Structure, function, and clinical use
CK Osborne et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
